Biocure Technology Inc.
BICTF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $6 | $0 | $197 |
| SG&A Expenses | $32 | $6 | $0 | $197 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $11 | $4 | $10 |
| Operating Expenses | $32 | $18 | $4 | $208 |
| Operating Income | -$32 | -$18 | -$4 | -$197 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$2 | -$4 | -$2 | -$12 |
| Pre-Tax Income | -$34 | -$21 | -$6 | -$210 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$34 | -$21 | -$6 | -$210 |
| % Margin | – | – | – | – |
| EPS | -0.002 | -0.002 | -0.001 | -0.005 |
| % Growth | -16.7% | -200% | 86.7% | – |
| EPS Diluted | -0.002 | -0.002 | -0.001 | -0.005 |
| Weighted Avg Shares Out | 16,105 | 12,148 | 10,444 | 46,364 |
| Weighted Avg Shares Out Dil | 16,105 | 12,148 | 10,444 | 46,024 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $2 | $4 | $2 | $3 |
| Depreciation & Amortization | $0 | $0 | $0 | $197 |
| EBITDA | -$32 | -$18 | -$4 | -$208 |
| % Margin | – | – | – | – |